310 results
8-K
EX-10.1
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
Reimbursement. The Company will reimburse you for all reasonable and necessary expenses incurred by you in connection with performing your duties … with their original schedule.
All in-kind benefits provided and expenses eligible for reimbursement under this Agreement shall be provided
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
4 Oct 24
Departure of Directors or Certain Officers
4:05pm
or cancel any of its benefits plans or programs at any time.
5. Expense Reimbursement. The Company will reimburse you for all reasonable and necessary … of the installments shall be payable in accordance with their original schedule.
All in-kind benefits provided and expenses eligible for reimbursement under
8-K
EX-10.2
ORKA
Oruka Therapeutics Inc.
13 Sep 24
Oruka Therapeutics Announces $200 Million Private Placement
4:02pm
which person is later determined to not be entitled to such payment shall return such payment (including reimbursement of expenses) to the person
8-K
EX-10.25
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
”). The total fees for Services shall not exceed the amount set out in the Schedule without an amendment to this Agreement.
Reimbursement for Expenses … . Certain expenses may be identified on the relevant Schedule as reimbursable by Oruka. If and only if the Schedule provides for the reimbursement
8-K
EX-3.6
ORKA
Oruka Therapeutics Inc.
5 Sep 24
Oruka Therapeutics Announces Closing of Merger with ARCA biopharma and Previously Announced Private Placement of $275 Million
5:18pm
with any person or entity other than the Corporation with respect to any direct or indirect compensation, reimbursement or indemnification in connection … , for their services on the Board of Directors and its committees, and such reimbursement of expenses, as may be fixed or determined by resolution
424B3
ri27uqe r1z6t
1 Aug 24
Prospectus supplement
4:10pm
425
54jqhwe7udb6 9pd77y
3 Apr 24
Business combination disclosure
7:33am
8-K
EX-2.1
qqw8a3le dny3
3 Apr 24
ARCA biopharma and Oruka Therapeutics Announce Merger Agreement
7:31am